medlr news

Shilpa Medicare Introduces Hybrid CDMO Model at DCAT 2025

Shilpa Medicare introduces its hybrid CDMO at DCAT 2025, offering a dual-service model with tailored development partnerships and exclusive B2B licensing, enabling pharma companies to accelerate market entry while leveraging Shilpa’s expertise in oncology, biologics, and peptide manufacturing.

medlr news

India’s First Intestinal Rehabilitation Centre Opens in Mumbai

Rela Hospital introduces India’s first Intestinal Rehabilitation Centre, offering specialized medical, surgical, and nutritional care for children with intestinal failure and complex gastrointestinal conditions.

medlr news

Zydus Acquires 86% Stake in Amplitude Surgical: A Strategic Move in MedTech

Zydus Lifesciences is set to acquire 86% of Amplitude Surgical, strengthening its presence in MedTech with innovative orthopedic solutions.

healthcare news

Glenmark Launches Glempa Range to Combat Diabetes and Heart Disease

Glenmark introduces Glempa, a new range of Empagliflozin-based medications to manage type 2 diabetes and cardiovascular risks, offering flexible treatment options for better health outcomes.

Medlr

Alkem Labs Cuts Diabetes Drug Cost by 80% with Empanorm Launch

Alkem Labs introduces Empanorm, an affordable generic empagliflozin, reducing costs by 80% and enhancing diabetes care with patient-friendly features.

Medlr

Aster DM Healthcare Promoters Reduce Share Pledge to 41% After Debt Refinancing

Aster DM Healthcare promoters have reduced their pledged shares from 99% to 41% after refinancing with JP Morgan, HSBC, and Barclays, improving financial stability and loan terms.

Medlr

AstraZeneca Pharma India Secures CDSCO Approval for Durvalumab in LS-SCLC Treatment

AstraZeneca Pharma India gains CDSCO approval for durvalumab in LS-SCLC, marking a breakthrough in early-stage lung cancer treatment post-CRT.

Medlr

Sun Pharma to Acquire Checkpoint Therapeutics in Strategic Oncology Expansion

Sun Pharma is set to acquire Checkpoint Therapeutics, expanding its oncology portfolio with the FDA-approved Unloxcyt for advanced cSCC treatment.

Medlr

Merck Life Science Launches Formulation & Technology Centre in Navi Mumbai

Merck Life Science unveils its Formulation & Technology Centre in Navi Mumbai, fostering industry collaboration and accelerating drug development.

Medlr

Venus Remedies Partners with Infex Therapeutics for MET-X Development in India

Venus Remedies collaborates with Infex Therapeutics to develop MET-X, a groundbreaking MBL inhibitor aimed at combating drug-resistant infections in India.

medlr news

Sterling Hospitals Elevates Cancer Care with ‘Hemato-Onco Update 2.0’

Sterling Hospitals' ‘Hemato-Onco Update 2.0’ brought together experts to discuss cutting-edge advancements in hemato-oncology, including CAR T-cell therapy, AI-driven diagnostics, and patient-centric care, reinforcing the hospital’s commitment to innovation and excellence in cancer treatment.

medlr news

Granules India Expands into Peptide Segment with Senn Chemicals Acquisition

Granules India enters the peptide and CDMO sector with the acquisition of Senn Chemicals AG, strengthening its innovation-driven pharmaceutical expansion.

medlr news

Senores Pharmaceuticals Acquires 14 ANDAs from Dr. Reddy’s in $1.13B Market Move

Senores Pharmaceuticals expands its U.S. market presence with the acquisition of 14 ANDAs from Dr. Reddy’s, strengthening its global portfolio.

healthcare news

Botanic Healthcare Invests ₹26Cr in New Himachal Pradesh Facility, Creating 200 Jobs

Botanic Healthcare invests ₹26Cr in a new Himachal Pradesh facility, boosting production by 50% and creating 200 jobs, reinforcing innovation and sustainability.

News

APICES Studio, HOSMART Join Forces for Advanced Healthcare Facility Development

APICES Studio joins forces with HOSMART, combining design prowess and healthcare management for progressive healthcare infrastructure. This alliance focuses on innovation and expertise to meet India's evolving healthcare demands.